LLY Gets FDA Nod, MRK Scores Legal Win, AFFX Pursued By Origin Technologies

A federal jury has ruled in favor of Merck & Co. Inc. (MRK) and Ionis Pharmaceuticals Inc. (IONS) in a patent dispute related to Gilead's (GILD) Sofosbuvir-based medicines for the treatment of hepatitis C virus, including Sovladi and Harvoni.

from RTT - Biotech http://ift.tt/1U84jqO
via IFTTT